In lung cancer, the presence of immature dendritic cells led to poor prognosis due to overexpression of programmed cell death-L1 (PD-L1) and programmed cell death-L2 (PD-L2) to inhibit T cell proliferation and activation [20,21]. This evidence concerns the gene PDCD1LG2 and lung carcinoma.